Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL

被引:44
|
作者
Miller, Barbra S. [1 ]
England, Barry G. [1 ]
Nehs, Matthew [1 ]
Burney, Richard E. [1 ]
Doherty, Gerard M. [1 ]
Gauger, Paul G. [1 ]
机构
[1] Univ Michigan Hosp & Hlth Ctr, Ann Arbor, MI USA
关键词
D O I
10.1016/j.surg.2006.07.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Common guidelines for intraoperative parathyroid hormone (IOPTH) interpretation are based. on, clearly elevated baseline parathyroid hormone (PTH) values. We hypothesize that patients with low-baseline levels (< 100 pg/mL) have a higher incidence of multigland disease (MGD) and display differences in PTH kinetics compared with patients with high-baseline levels. Methods. Vile retrospectively reviewed the cases of 1151 patients with primacy hyperparathyroidism who,underwent parathyroidectomy with IOPTH monitoring. Of these, 141 patients had low-baseline values. Multiple comparisons were made between the low-baseline and high-baseline groups. Results. Twenty-six percent of the low-baseline patients had MGD versus 15% of the high-baseline patients (P = .002). The PTH kinetics differed between groups after gland excision at both 5 and 10 minutes. Adherence solely to the "50% rule" during minimally invasive parathyroidectomy potentially would have missed 25% of patients with MGD in the low-baseline group versus 10% in the high-baseline group; 5.7% of the low-baseline patients had persistent or recurrent hypercalcemia versus 2.9% of the high-baseline patients. Conclusion. MGD is significantly more prevalent among low-baseline patients, and PTH kinetics are somewhat different between groups. The current guidelines that are used for IOPTH monitoring may not be ideal for use in this low-baseline group and will likely need to be revised after further study of this group of Patients.
引用
收藏
页码:883 / 889
页数:7
相关论文
共 50 条
  • [31] Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels
    Horányi, J
    Duffek, L
    Szlávik, R
    Darvas, K
    Lakatos, P
    Tóth, M
    Rácz, K
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (11) : 1095 - 1099
  • [32] Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism
    Graceffa, Giuseppa
    Cipolla, Calogero
    Calagna, Silvia
    Contino, Silvia
    Melfa, Giuseppina
    Orlando, Giuseppina
    Antonini, Riccardo
    Corigliano, Alessandro
    Proclama, Maria Pia
    Mazzola, Sergio
    Cocorullo, Gianfranco
    Scerrino, Gregorio
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism
    Giuseppa Graceffa
    Calogero Cipolla
    Silvia Calagna
    Silvia Contino
    Giuseppina Melfa
    Giuseppina Orlando
    Riccardo Antonini
    Alessandro Corigliano
    Maria Pia Proclamà
    Sergio Mazzola
    Gianfranco Cocorullo
    Gregorio Scerrino
    Scientific Reports, 12
  • [34] Intraoperative parathyroid hormone assay and parathyroid reoperations
    Sebag, F
    Shen, W
    Brunaud, L
    Kebebew, E
    Duh, QY
    Clark, OH
    SURGERY, 2003, 134 (06) : 1049 - 1055
  • [35] Interpretation of Parathyroid Hormone Levels in Renal Impairment
    Nwosu, Ifeanyi F.
    Ibeson, Cece E.
    Olawoye, Adedoyin
    Kyaw, Htin
    Kumar, Kelash
    Odigwe, Celestine
    Nwosu, Chukwunonso A.
    Oshunsanya, Anthony
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [36] Near-patient parathyroid hormone immunoassay for intraoperative monitoring in parathyroid surgery
    Kao, PC
    van Heerden, JA
    JOURNAL OF CLINICAL LIGAND ASSAY, 1999, 22 (02): : 123 - 128
  • [37] Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring
    Thompson, GB
    Grant, CS
    Perrier, ND
    Harman, R
    Hodgson, SF
    Ilstrup, D
    van Heerden, JA
    ARCHIVES OF SURGERY, 1999, 134 (07) : 699 - 704
  • [38] Surgical Treatment of Mediastinal Parathyroid Adenoma: Rationale for Intraoperative Parathyroid Hormone Monitoring
    Sagan, Dariusz
    Gozdziuk, Kazimierz
    ANNALS OF THORACIC SURGERY, 2010, 89 (06): : 1750 - 1755
  • [39] Intraoperative Parathyroid Hormone Monitoring in Patients with Recognized Multiglandular Primary Hyperparathyroidism
    David T. Hughes
    Barbra S. Miller
    Gerard M. Doherty
    Paul G. Gauger
    World Journal of Surgery, 2011, 35 : 336 - 341
  • [40] Opinion regarding hypercalcemia with a parathyroid hormone level of &lt;50 pg/mL: Is this primary hyperparathyroidism?
    Sharma, Nitisha
    Kumar, Chitresh
    SURGERY, 2023, 173 (04) : 1103 - 1104